0 Mėgstami
0Krepšelis

Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

111,43 
111,43 
2025-07-31 111.4300 InStock
Nemokamas pristatymas į paštomatus per 18-22 darbo dienų užsakymams nuo 19,00 

Knygos aprašymas

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

Informacija

Autorius: Heiko Schön
Serija: Corporate Finance and Governance
Leidėjas: Peter Lang
Išleidimo metai: 2015
Knygos puslapių skaičius: 202
ISBN-10: 3631663811
ISBN-13: 9783631663813
Formatas: Knyga kietu viršeliu
Kalba: Anglų
Žanras: Multinationals

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective“

Būtina įvertinti prekę

Goodreads reviews for „Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective“